申请人:Brown University Research Foundation
公开号:US05278167A1
公开(公告)日:1994-01-11
Novel 6-pyridyl substituted pyrimidine derivatives are disclosed for use as antiviral agents, particularly for the treatment of retroviral infections such as HIV infections and related disorders, as well as for use in anti-cancer therapies to improve the efficacy of anti-cancer therapeutics. These compounds and their pharmacologically acceptable salts operate to disrupt viral replication an exhibit lower cell toxicity, thereby providing more efficient agents for use alone or in conjunction with other chemical or biological agents to provide prolonged antiviral therapy. In addition, the compounds can be used to increase the efficacy of anti-cancer therapeutics including 5-fluropyrimidines such as 5-fluorouracil, thereby reducing the dosage requirement of the therapeutic in anti-cancer therapies so as to decrease toxic effects to the host.
披露了一种新型6-吡啶基取代嘧啶衍生物,可用作抗病毒剂,特别用于治疗逆转录病毒感染,如HIV感染和相关疾病,以及用于抗癌治疗,以提高抗癌治疗药物的疗效。这些化合物及其药理学上可接受的盐作用于破坏病毒复制并表现出更低的细胞毒性,从而提供更有效的药剂,可单独使用或与其他化学或生物药剂结合使用,以提供长期的抗病毒治疗。此外,这些化合物还可用于提高抗癌治疗药物的疗效,包括5-氟嘧啶类药物,如5-氟尿嘧啶,从而降低抗癌治疗药物的剂量要求,以减少对宿主的毒性影响。